Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 4/20 | 0.74 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.74 |
| ▸ | TYR | P14679 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.54 |
| ▸ | HTR1A | P08908 | 1/20 | 0.54 |
| ▸ | HTR3A | P46098 | 1/20 | 0.54 |
| ▸ | BACE1 | P56817 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.54 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24193843 | 0.90 | LTA4H (0.82) | LTA4HESR1ESR2TYRCA2 | |
| SCHEMBL69344 | 0.86 | ESR1 (1.00) | LTA4HESR1ESR2TYRCA2 | |
| SCHEMBL3873458 | 0.86 | ESR1 (1.00) | LTA4HESR1ESR2TYRCA2 | |
| SCHEMBL10149325 | 0.86 | LTA4H (0.74) | LTA4HESR1ESR2TYRBACE1 | |
| SCHEMBL18328929 | 0.83 | LTA4H (0.71) | LTA4HESR1ESR2TYRTAAR1 | |
| SCHEMBL11674563 | 0.83 | LTA4H (0.71) | LTA4HESR1ESR2TYRTAAR1 | |
| Dihydropinosylvin SCHEMBL501070 | 0.82 | LTA4H (0.70) | LTA4HESR1ESR2TYRCALM1 | |
| SCHEMBL716875 | 0.80 | ESR1 (0.67) | LTA4HESR1ESR2TYRCA2 | |
| SCHEMBL29862145 | 0.80 | CALM1 (0.86) | LTA4HESR1ESR2CALM1PTPN1 | |
| SCHEMBL16568144 | 0.80 | CALM1 (0.86) | LTA4HESR1ESR2CALM1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 470 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078269-A1 | POLYMERIC COMPOSITIONS WITH STILBENE-BASED PROCESSING AIDS | Cambium Biomaterials, Inc. (US) | 2026-03-19 | — | — | US | claimed |
| EP-4687856-A2 | GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING | JDS Therapeutics, LLC (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2025227265-A1 | METHODS FOR CONCENTRATING POLYPHENOLIC COMPOUNDS | CANURTA INC. (CA) | 2025-11-06 | — | — | WO | claimed |
| EP-4601749-A1 | ORAL COMPOSITIONS AND RELATED METHODS | Colgate-Palmolive Company (US) | 2025-08-20 | — | — | EP | claimed |
| CN-116162017-B | Preparation method of trans-resveratrol | 西安久启生物科技有限公司 | 2025-02-11 | — | — | CN | claimed |
| WO-2024229159-A2 | GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING | JDS THERAPEUTICS, LLC (US) | 2024-11-07 | — | — | WO | claimed |
| US-20240366525-A1 | GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING | JDS THERAPEUTICS, LLC | 2024-11-07 | — | — | US | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| CN-118286188-A | Application of dihydroresveratrol in preparation of subtype adenovirus inhibitor | 广州医科大学附属妇女儿童医疗中心 | 2024-07-05 | — | — | CN | claimed |
| WO-2024112884-A1 | BIOSYNTHESIS OF DIHYDROCHALCONES AND DIHYDROSTILBENOIDS | CONAGEN INC. (US) | 2024-05-30 | — | — | WO | claimed |
| WO-2016193504-A1 | BIOSYNTHESIS OF PHENYLPROPANOID AND DIHYDROPHENYLPROPANOID DERIVATIVES | EVOLVA SA (CH) | 2016-12-08 | — | — | WO | claimed |
| US-20160311976-A1 | PHTHALONITRILES DERIVED FROM POLYPHENOLS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2016-10-27 | — | — | US | claimed |
| US-8853343-B1 | Thermoset compositions from plant polyphenols | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2014-10-07 | — | — | US | claimed |
| US-8728453-B2 | Combinatorial polymeric compositions for drug delivery | INNOVOTECH, LLC (US) | 2014-05-20 | — | — | US | claimed |
| US-20140018437-A1 | TREATMENT OF INFLAMMATORY AND INFECTIOUS SKIN DISORDERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-01-16 | — | — | US | claimed |
| US-20140017341-A1 | COMPOSITION AND METHOD FOR TREATING FAT TISSUES AND INFLAMMATORY PROCESSES | GOURLAOUEN BRIGITTE (FR) | 2014-01-16 | — | — | US | claimed |
| EP-2629744-A1 | PRODUCT FOR TREATING CELLULITE, SKIN AGEING AND FOR PREVENTING INFLAMMATORY PROCESSES | Gourlaouen, Brigitte (FR) | 2013-08-28 | — | — | EP | claimed |
| US-20120220749-A1 | COMBINATIORIAL POLYMERIC COMPOSITIONS FOR DRUG DELIVERY | INNOVOTECH, LLC | 2012-08-30 | — | — | US | claimed |
| WO-2012052685-A1 | PRODUCT FOR TREATING CELLULITE, SKIN AGEING AND FOR PREVENTING INFLAMMATORY PROCESSES | GOURLAOUEN BRIGITTE (FR) | 2012-04-26 | — | — | WO | claimed |
| EP-2049091-B1 | CASEIN COMPLEXES | DSM IP ASSETS BV (NL) | 2010-12-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311976-A1 | PHTHALONITRILES DERIVED FROM POLYPHENOLS | NR3C2, MECP2, EBP | LTA4H 3677/4885ESR1 351/4885ESR2 450/4885 |
| US-20260078269-A1 | POLYMERIC COMPOSITIONS WITH STILBENE-BASED PROCESSING AIDS | SMCHD1, TERB1, NLRP3 | LTA4H 872/4885ESR1 154/4885ESR2 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.